X4 Pharmaceuticals (XFOR) Debt to Equity (2015 - 2026)
X4 Pharmaceuticals (XFOR) debt to equity from Dec 31, 2015 to Mar 31, 2026. The current X4 Pharmaceuticals (XFOR) debt to equity is 44.52%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of X4 Pharmaceuticals (XFOR)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 40.26% | -88.11% |
| 2024 | 338.60% | +217.07% |
| 2023 | 106.79% | +135.21% |
| 2022 | 45.40% | -13.81% |
| 2021 | 52.68% | +15.58% |
| 2020 | 45.58% | +194.47% |
| 2019 | 15.48% | -219.32% |
| 2018 | -12.97% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
Comparison X4 Pharmaceuticals (XFOR) debt to equity with competitors
X4 Pharmaceuticals (XFOR) debt to equity is 44.52%.